Novel Agents in Heavily Pretreated Metastatic Gastric Cancer: More Shadows Than Lights

Figure 2

Data of median progression-free survival (PFS) of the experimental arm and placebo arm and delta PFS difference between PFS of the experimental arm and placebo arm.